Biphasic regulation of Na+-HCO3- cotransporter by angiotensin II type 1A receptor. 2002

Shoko Horita, and Yanan Zheng, and Chiaki Hara, and Hideomi Yamada, and Motoei Kunimi, and Shigeo Taniguchi, and Shu Uwatoko, and Takeshi Sugaya, and Atsuo Goto, and Toshiro Fujita, and George Seki
Department of Internal Medicine, Faculty of Medicine, Tokyo University, Tokyo, Japan.

Although angiotensin (Ang) II is known to regulate renal proximal transport in a biphasic way, the receptor subtype(s) mediating these Ang II effects remained to be established. To clarify this issue, we compared the effects of Ang II in wild-type mice (WT) and Ang II type 1A receptor-deficient mice (AT(1A) KO). The Na+-HCO3- cotransporter (NBC) activity, analyzed in isolated nonperfused tubules with a fluorescent probe, was stimulated by 10(-10) mol/L Ang II but was inhibited by 10(-6) mol/L Ang II in WT. Although valsartan (AT1 antagonist) blocked both stimulation and inhibition by Ang II, PD 123,319 (AT2 antagonist) did not modify these effects of Ang II. In AT1A KO, in contrast, this biphasic regulation was lost, and only stimulation of NBC activity by 10(-6) mol/L Ang II was observed. This stimulation was blocked by valsartan but not by PD 123,319. More than 10(-8) mol/L Ang II induced a transient increase in cell Ca2+ concentrations in WT, which was again blocked by valsartan but not by PD 123,319. However, up to 10(-5) mol/L Ang II did not increase cell Ca2+ concentrations in AT1A KO. Finally, the addition of arachidonic acid inhibited the NBC activity similarly in WT and AT(1A) KO, suggesting that the inhibitory pathway involving P-450 metabolites is preserved in AT(1A) KO. These results indicate that AT(1A) mediates the biphasic regulation of NBC. Although low-level expression of AT(1B) could be responsible for the stimulation by 10(-6) mol/L Ang II in AT1A KO, no evidence was obtained for AT2 involvement.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D007424 Intracellular Fluid The fluid inside CELLS. Fluid, Intracellular,Fluids, Intracellular,Intracellular Fluids
D007687 Kidney Tubules, Proximal The renal tubule portion that extends from the BOWMAN CAPSULE in the KIDNEY CORTEX into the KIDNEY MEDULLA. The proximal tubule consists of a convoluted proximal segment in the cortex, and a distal straight segment descending into the medulla where it forms the U-shaped LOOP OF HENLE. Proximal Kidney Tubule,Proximal Renal Tubule,Kidney Tubule, Proximal,Proximal Kidney Tubules,Proximal Renal Tubules,Renal Tubule, Proximal,Renal Tubules, Proximal,Tubule, Proximal Kidney,Tubule, Proximal Renal,Tubules, Proximal Kidney,Tubules, Proximal Renal
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D011945 Receptors, Angiotensin Cell surface proteins that bind ANGIOTENSINS and trigger intracellular changes influencing the behavior of cells. Angiotensin Receptor,Angiotensin Receptors,Angiotensin II Receptor,Angiotensin III Receptor,Receptor, Angiotensin II,Receptor, Angiotensin III,Receptor, Angiotensin
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005456 Fluorescent Dyes Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. Flourescent Agent,Fluorescent Dye,Fluorescent Probe,Fluorescent Probes,Fluorochrome,Fluorochromes,Fluorogenic Substrates,Fluorescence Agents,Fluorescent Agents,Fluorogenic Substrate,Agents, Fluorescence,Agents, Fluorescent,Dyes, Fluorescent,Probes, Fluorescent,Substrates, Fluorogenic

Related Publications

Shoko Horita, and Yanan Zheng, and Chiaki Hara, and Hideomi Yamada, and Motoei Kunimi, and Shigeo Taniguchi, and Shu Uwatoko, and Takeshi Sugaya, and Atsuo Goto, and Toshiro Fujita, and George Seki
August 1993, The American journal of physiology,
Shoko Horita, and Yanan Zheng, and Chiaki Hara, and Hideomi Yamada, and Motoei Kunimi, and Shigeo Taniguchi, and Shu Uwatoko, and Takeshi Sugaya, and Atsuo Goto, and Toshiro Fujita, and George Seki
October 1995, Journal of the American Society of Nephrology : JASN,
Shoko Horita, and Yanan Zheng, and Chiaki Hara, and Hideomi Yamada, and Motoei Kunimi, and Shigeo Taniguchi, and Shu Uwatoko, and Takeshi Sugaya, and Atsuo Goto, and Toshiro Fujita, and George Seki
February 2008, Journal of the American Society of Nephrology : JASN,
Shoko Horita, and Yanan Zheng, and Chiaki Hara, and Hideomi Yamada, and Motoei Kunimi, and Shigeo Taniguchi, and Shu Uwatoko, and Takeshi Sugaya, and Atsuo Goto, and Toshiro Fujita, and George Seki
June 2004, American journal of physiology. Cell physiology,
Shoko Horita, and Yanan Zheng, and Chiaki Hara, and Hideomi Yamada, and Motoei Kunimi, and Shigeo Taniguchi, and Shu Uwatoko, and Takeshi Sugaya, and Atsuo Goto, and Toshiro Fujita, and George Seki
April 1995, Proceedings of the National Academy of Sciences of the United States of America,
Shoko Horita, and Yanan Zheng, and Chiaki Hara, and Hideomi Yamada, and Motoei Kunimi, and Shigeo Taniguchi, and Shu Uwatoko, and Takeshi Sugaya, and Atsuo Goto, and Toshiro Fujita, and George Seki
March 1995, The American journal of physiology,
Shoko Horita, and Yanan Zheng, and Chiaki Hara, and Hideomi Yamada, and Motoei Kunimi, and Shigeo Taniguchi, and Shu Uwatoko, and Takeshi Sugaya, and Atsuo Goto, and Toshiro Fujita, and George Seki
February 2006, American journal of physiology. Renal physiology,
Shoko Horita, and Yanan Zheng, and Chiaki Hara, and Hideomi Yamada, and Motoei Kunimi, and Shigeo Taniguchi, and Shu Uwatoko, and Takeshi Sugaya, and Atsuo Goto, and Toshiro Fujita, and George Seki
June 1997, Wiener klinische Wochenschrift,
Shoko Horita, and Yanan Zheng, and Chiaki Hara, and Hideomi Yamada, and Motoei Kunimi, and Shigeo Taniguchi, and Shu Uwatoko, and Takeshi Sugaya, and Atsuo Goto, and Toshiro Fujita, and George Seki
September 1989, Kidney international,
Shoko Horita, and Yanan Zheng, and Chiaki Hara, and Hideomi Yamada, and Motoei Kunimi, and Shigeo Taniguchi, and Shu Uwatoko, and Takeshi Sugaya, and Atsuo Goto, and Toshiro Fujita, and George Seki
February 1999, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!